title: [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
authors.forename: J
authors.initials: J
authors.lastname: Turc
authors.forename: O
authors.initials: O
authors.lastname: Eve
authors.forename: D
authors.initials: D
authors.lastname: Tran Van
authors.forename: P-F
authors.initials: PF
authors.lastname: Wey
authors.forename: J-Y
authors.initials: JY
authors.lastname: Martinez
mesh_terms: D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D001682:Biological Availability; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D003363:Cost Control; D003422:Critical Care / Q000191:economics*; D016527:Drug Costs; D004750:Enteral Nutrition; D006801:Humans; D007275:Injections, Intravenous / Q000191:economics; D007362:Intensive Care Units / Q000191:economics; D015242:Ofloxacin / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D012189:Retrospective Studies
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D015242:Ofloxacin